Resmed Financial Statements From 2010 to 2026
| RSMDF Stock | USD 26.73 0.52 1.91% |
Check Resmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Resmed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Resmed financial statements analysis is a perfect complement when working with Resmed Valuation or Volatility modules.
Resmed |
Resmed Inc DRC Company Return On Equity Analysis
Resmed's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Resmed Return On Equity | 0.24 |
Most of Resmed's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Resmed Inc DRC has a Return On Equity of 0.2352. This is 100.98% lower than that of the Healthcare sector and 103.93% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 175.87% lower than that of the firm.
Resmed Inc DRC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Resmed competition to find correlations between indicators driving Resmed's intrinsic value. More Info.Resmed Inc DRC is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Resmed Inc DRC is roughly 2.04 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.About Resmed Financial Statements
Resmed stakeholders use historical fundamental indicators, such as Resmed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Resmed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Resmed's assets and liabilities are reflected in the revenues and expenses on Resmed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Resmed Inc DRC. Please read more on our technical analysis and fundamental analysis pages.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. Resmed Inc operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8160 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Resmed Pink Sheet
Resmed financial ratios help investors to determine whether Resmed Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.